| Enterprise’s $33.1 Million Series B | https://endpts.com/exclusive-uk-biotech-raises-33-1m-to-test-cf-drug-in-patients-who-dont-have-cftr-mutation/ | 29/01/2024 |
Immunocore’s $350 Million Convertible Senior Notes Offering | https://www.globenewswire.com/news-release/2024/01/31/2820694/0/en/Immunocore-Prices-Upsized-Convertible-Senior-Notes-Offering.html | 31/01/2024 |
| TCG Labs-Soleil’s $400 Million Fund Raise | https://www.globenewswire.com/news-release/2024/02/01/2822419/0/en/TCG-Labs-Soleil-Raises-Inaugural-Fund-of-Over-400-Million.html?fbclid=IwAR0nsPPt7YoMiufeXqegFnZ_X_v4c_T4fObIf2SAnH_TB9Wsc1aZZAe5pEs | 01/02/2024 |
| Vera’s $288 Million Public Offering | https://ir.veratx.com/news-releases/news-release-details/vera-therapeutics-announces-closing-upsized-public-offering-0 | 01/02/2024 |
| ARCH’s $3 Billion Fund Raise | https://endpts.com/arch-one-of-life-sciences-premier-investors-eyes-3b-for-13th-fund/ | 02/02/2024 |
| https://www.statnews.com/2024/02/02/arch-venture-partners-is-raising-3-billion-for-a-life-sciences-fund/ | |
| Vaxcyte’s $862.5 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/02/2823089/0/en/Vaxcyte-Announces-Closing-of-862-5-Million-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html | 02/02/2024 |
| https://endpts.com/vaxcyte-prices-750m-offering-one-of-biotechs-largest-as-it-goes-up-against-big-pharmas-pneumococcal-vaccines/ | |
| Tyra’s $200 Million Private Placement | https://ir.tyra.bio/news-releases/news-release-details/tyra-biosciences-inc-announces-200-million-private-placement | 02/02/2024 |
| Alto’s $128.6 Million IPO.. | https://www.businesswire.com/news/home/20240201667961/en/Alto-Neuroscience-Announces-Pricing-of-Upsized-Initial-Public-Offering | 02/02/2024 |
| https://medcitynews.com/2024/02/biotech-ipo-alto-neuroscience-depression-biomarker-psychiatric-drugs/ | |
| Fractyl’s $110 Million IPO. | https://medcitynews.com/2024/02/metabolic-disorder-biotech-ipo-medical-device-obesity-fractyl-health/ | 02/02/2024 |
| https://www.globenewswire.com/news-release/2024/02/02/2822565/0/en/Fractyl-Health-Announces-Pricing-of-Initial-Public-Offering.html | |
| Corbus’s $94.5 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/02/2823041/0/en/Corbus-Pharmaceuticals-Announces-Closing-of-94-5-Million-Public-Offering-of-Common-Stock-including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html | 02/02/2024 |
Vivet Therapeutics $5 Million Investment From French Innovation Program | https://www.precisionmedicineonline.com/business-news/vivet-therapeutics-nabs-eu49m-investment-french-innovation-program-develop-ctx-gene | 02/02/2024 |
| NexImmune's $4 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/02/2823027/0/en/NexImmune-Announces-3-67-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html | 02/02/2024 |
Novo Holding’s $16.5 Billion Acquisition of Catalent (CTLT) | https://www.streetinsider.com/Corporate+News/Novo+Holdings+to+buy+Catalent+%28CTLT%29+for+%2416.5+billion/22718329.html | 05/02/2024 |
| https://medcitynews.com/2024/02/novo-holdings-catalent-acquisition-novo-nordisk-glp1/?utm_medium=email&_hsmi=292941241&_hsenc=p2ANqtz-_Gl2ypNoFjzCk7MMSePcDSHtM3gwvBYJNG0J94he4r4Pw0Eajj6mo0bQPo0pbI97T6yeL4b_laFji6w6jFngb6SR6GDw&utm_content=292941241&utm_source=hs_email | |
| https://www.fiercepharma.com/pharma/novo-holdings-antes-165b-poach-catalent-selling-three-fill-finish-sites-novo-nordisk | |
| Novartis’s $2.9 Billion Acquisition of MorphoSys | https://www.reuters.com/markets/deals/novartis-acquires-cancer-drug-developer-morphosys-29-bln-2024-02-05/ | 05/02/2024 |
| https://www.fiercebiotech.com/biotech/after-incytes-commercial-buy-novartis-shells-out-eu27b-newly-re-clinical-morphosys?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FiercePharma+Tracker&oly_enc_id=8675F1143345E3C | |
| Adverum’s $127.5 Million Private Placement | https://www.streetinsider.com/Corporate+News/Novo+Holdings+to+buy+Catalent+%28CTLT%29+for+%2416.5+billion/22718329.html | 05/02/2024 |
| Silence’s $120 Million Private Placement | https://finance.yahoo.com/news/silence-therapeutics-announces-oversubscribed-120-130000619.html | 05/02/2024 |
Coherus Amends Term Loan Agreement with Pharmakon Advisors, L.P. | https://www.globenewswire.com/news-release/2024/02/05/2823475/33333/en/Coherus-Amends-Term-Loan-Agreement-with-Pharmakon-Advisors-LP.html | 05/02/2024 |
| The top 10 biopharma M&A deals of 2023 | https://www.fiercepharma.com/special-reports/top-10-biopharma-ma-deals-2023?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=8675F1143345E3C | 05/02/2024 |
| Cencora's $500 Million Debt Financing | https://www.businesswire.com/news/home/20240205856996/en | 06/02/2024 |
| Gilead's $300 Million Tizona Opt-Out | https://www.fiercebiotech.com/biotech/gilead-will-not-buy-tizona-after-paying-300m-right-do-so?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=9674G9134345I7D | 06/02/2024 |
| 4D Molecular's $250 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/07/2824844/0/en/4D-Molecular-Therapeutics-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html | 06/02/2024 |
| Immunome's $88 Million Purchase of Ayala Asset | https://www.biospace.com/article/releases/immunome-to-acquire-al102-a-phase-3-asset-for-the-treatment-of-desmoid-tumors-from-ayala-pharmaceuticals/ | 06/02/2024 |
| NeOnc's $75 Million IPO | https://www.renaissancecapital.com/IPO-Center/News/103151/Brain-cancer-biotech-NeOnc-Technologies-sets-terms-for-%2475-million-IPO | 06/02/2024 |
| Attralus's $56 Million Venture Financing | https://attralus.com/press-releases/attralus-closes-56-million-financing | 06/02/2024 |
| Jasper's $50 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/06/2824392/0/en/Jasper-Therapeutics-Announces-Pricing-of-50-Million-Underwritten-Offering-of-Common-Stock.html | 06/02/2024 |
| Elemind's $12 Million Seed Round | https://www.businesswire.com/news/home/20240206128855/en/Leading-Neuroscientists-Bring-Elemind-Out-of-Stealth-Close-12-Million-Seed-Round-for-AI-enhanced-Neurotech-Wearable | 06/02/2024 |
| Revelation's $6 Million Public Offering | https://www.businesswire.com/news/home/20240205917010/en/Revelation-Biosciences-Inc.-Announces-Closing-of-6.2-Million-Public-Offering | 06/02/2024 |
| Top 10 Biopharma Takeover Targets Of 2024 | https://www.genengnews.com/a-lists/top-10-biopharma-takeover-targets-of-2024/ | 07/02/2024 |
| Scion's $310 Million Fund Raise | https://www.prnewswire.com/news-releases/scion-life-sciences-launches-with-oversubscribed-310-million-fund-to-create-and-build-exceptional-biotech-companies-302055568.html | 07/02/2024 |
| https://www.fiercebiotech.com/biotech/two-former-apple-tree-investors-roll-toward-new-fund-launching-310-million?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=9674G9134345I7D | |
| https://www.biopharmadive.com/news/scion-life-sciences-venture-capital-fund-launch/706625/ | |
| Alto's $147 Million IPO...More More | https://investors.altoneuroscience.com/news/news-details/2024/Alto-Neuroscience-Announces-Closing-of-Upsized-Initial-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares/default.aspx | 07/02/2024 |
| https://www.businesswire.com/news/home/20240201667961/en/Alto-Neuroscience-Announces-Pricing-of-Upsized-Initial-Public-Offering | |
| https://medcitynews.com/2024/02/biotech-ipo-alto-neuroscience-depression-biomarker-psychiatric-drugs/ | |
| PepGen's $80 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/07/2825084/0/en/PepGen-Announces-Pricing-of-80-1-Million-Underwritten-Offering-of-Common-Stock.html | 07/02/2024 |
| Kyverna's $319 Million IPO | https://medcitynews.com/2024/02/biotech-ipo-kyverna-cell-therapy-autoimmune-diseases/ | 08/02/2024 |
| https://www.biopharmadive.com/news/kyverna-ipo-price-lupus-cell-therapy-autoimmune/706836/ | |
| https://www.sec.gov/Archives/edgar/data/1994702/000119312524024683/d530411ds1a.htm#rom530411_5 | |
| https://www.fiercebiotech.com/biotech/kyverna-sets-ipo-range-eyeing-180m-haul-fund-broad-autoimmune-car-t-clinical-trial-program?fbclid=IwAR28Jdk1fqNunr11fWpeGNGrgdH6-4FHMfW3zvxRyAxQzheJSehsPkqpIZs | |
Autolus's $200 Million Equity Investment from BioNtech, $350 Million Public Offering | https://medcitynews.com/2024/02/cell-therapy-cancer-leukemia-lupus-biontech-autolus/?utm_medium=email&_hsmi=293460950&_hsenc=p2ANqtz-9lMXed2jjFoas_Cgqe-BUnx45Gm4zo0GWDBsPR55wI4OjzqGZaoKa0we5dO3SoWMx-IrepqFvw4UKigu46A-yGCV7neg&utm_content=293460950&utm_source=hs_email | 08/02/2024 |
| Mineralys's $120 Million Private Placement | https://ir.mineralystx.com/news-events/press-releases/detail/38/mineralys-therapeutics-announces-120-million-private | 08/02/2024 |
| Neurona's $120 Million Series E | https://finance.yahoo.com/news/neurona-therapeutics-raises-120m-advance-130000173.html | 08/02/2024 |
| BioXcel's $60 Million Public Offering | https://ir.bioxceltherapeutics.com/news-releases/news-release-details/bioxcel-therapeutics-announces-proposed-public-offering | 08/02/2024 |
| Tenaya's $50 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/08/2825960/0/en/Tenaya-Therapeutics-Announces-Pricing-of-Underwritten-Offering.html | 08/02/2024 |
| Immix’s $15 Million Public Offering | https://www.globenewswire.com/news-release/2024/02/08/2826486/0/en/Immix-Biopharma-Announces-Closing-of-15-Million-Public-Offering-of-Common-Stock.html | 08/02/2024 |
| https://www.globenewswire.com/news-release/2024/02/06/2823945/0/en/Immix-Biopharma-Announces-Pricing-of-15-Million-Public-Offering-of-Common-Stock.html | |
| Bullfrog's $5 Million Public Offering | https://ir.bullfrogai.com/news-events/press-releases/detail/41/bullfrog-ai-announces-closing-of-5-7-million-public-offering | 08/02/2024 |
Foghorn's $80 Million Equity Investment from Eli Lilly Part of Larger Partnering Deal | https://investor.lilly.com/news-releases/news-release-details/lilly-and-foghorn-announce-strategic-collaboration-novel | 09/02/2024 |
| https://www.ns-healthcare.com/news/lilly-foghorn-novel-oncology-drugs/ | |
| Sensorion's $55 Million Public Offering | https://www.morningstar.com/news/business-wire/20240208595169/sensorion-announces-a-505-million-financing-with-participation-from-new-and-existing-us-and-european-healthcare-specialist-investors | 09/02/2024 |
| YS Biopharma's $40 Million Private Placement | https://www.prnewswire.com/news-releases/ys-biopharma-announces-us40-million-private-placement-financing-302058494.html | 09/02/2024 |
| Lineage Cell's $14 Million Public Offering...More | https://www.businesswire.com/news/home/20240209732533/en/Lineage-Cell-Therapeutics-Announces-Closing-of-14.0-Million-Registered-Direct-Offering | 09/02/2024 |
| https://www.businesswire.com/news/home/20240206000006/en/Lineage-Cell-Therapeutics-Announces-14.0-Million-Registered-Direct-Offering | |
| Metagenomi’s $94 Million IPO...More | https://www.renaissancecapital.com/IPO-Center/News/103244/Gene-editing-biotech-Metagenomi-prices-IPO-at-$15-the-low-end-of-the-range | 09/02/2024 |
| https://www.biopharmadive.com/news/metagenomi-ipo-biotech-price-gene-editing/706923/ | |
| COUR's $105 Million Series A...More | https://medcitynews.com/2024/02/inflammation-immunology-startup-autoimmune-disease-nanoparticle-diabetes/ | 11/02/2024 |
| https://www.globenewswire.com/news-release/2024/01/30/2819700/0/en/COUR-Pharmaceuticals-Secures-105-Million-in-Series-A-Financing-Co-Led-by-Lumira-Ventures-and-Alpha-Wave-Ventures.html | |
| AbbVie's $10 Billion Acquisition of ImmunoGen | https://www.fiercepharma.com/pharma/abbvie-quickly-wraps-its-101b-buyout-immunogen-another-good-sign-biopharma-ma | 12/02/2024 |
| Gilead's $4.3 Billion Acquisition of CymaBay...More | https://www.gilead.com/news-and-press/press-room/press-releases/2024/2/gilead-sciences-expands-liver-portfolio-with-acquisition-of-cymabay-therapeutics | 12/02/2024 |
| https://medcitynews.com/2024/02/gileads-4-3b-cymabay-acquisition-adds-liver-disease-drug-under-fda-review/?utm_medium=email&_hsmi=293908514&_hsenc=p2ANqtz--DYAvffRrXbX4C3wj2m7MHzBTgol62BCpn0ifpmzVX8zDoPS_NRUvEETsKVMfU0CTnxEOaBPIfVcjP_QgzzxTiRIhgxA&utm_content=293908514&utm_source=hs_email | |
| Sana's $190 Million Public Offering...More | https://ir.sana.com/news-releases/news-release-details/sana-biotechnology-announces-closing-upsized-public-offering-and | 12/02/2024 |
| https://www.globenewswire.com/news-release/2024/02/08/2825690/0/en/Sana-Biotechnology-Announces-Pricing-of-Upsized-Public-Offering.html | |
Medicxi's $100 Million Combination of Six Startups to form Alys...More More | https://www.prnewswire.com/news-releases/alys-pharmaceuticals-launches-with-100m-financing-from-medicxi-to-advance-immuno-dermatology-focused-pipeline-302059124.html | 12/02/2024 |
| https://www.fiercebiotech.com/biotech/medixci-merges-six-dermatology-biotechs-one-adds-100m-funding-launch | |
| https://endpts.com/medicxi-combines-six-startups-to-form-immuno-dermatology-biotech-with-100m/ | |
NRx Pharmaceutical's $5 Million Warrant Grant To Alvogen and Lotus Pharmaceuticals For Advancement of Milestone | https://www.biospace.com/article/releases/nrx-pharmaceuticals-inc-nasdaq-nrxp-announces-advance-of-5-million-milestone-payment-from-partners-alvogen-inc-and-lotus-pharmaceutical-co-ltd-1975-tw-/#:~:text=NRx%20Pharmaceuticals%2C%20Inc.-,(Nasdaq%3A%20NRXP)%20Announces%20Advance%20of%20%245%20Million%20Milestone%20Payment,Ltd.%20(1975.TW)&text=NRx%20remains%20eligible%20for%20an,and%20commercialization%20of%20NRX%2D101. | 12/02/2024 |
CRISPR's $280 Registered Direct Offering ... More More | https://seekingalpha.com/pr/19621728-crispr-therapeutics-announces-280-million-registered-direct-offering?hasComeFromMpArticle=false | 13/02/2024 |
| https://www.streetinsider.com/Corporate+News/CRISPR+Therapeutics+%28CRSP%29+Prices+%24280M+Share+Offering+at+%2471.50sh/22761782.html | |
| https://markets.businessinsider.com/news/stocks/crispr-therapeutics-announces-280-million-registered-direct-offering-1033060908 | |
| BioAge's $170 Million Series D... More More | https://www.fiercebiotech.com/biotech/bioage-labs-closes-170m-series-d-keep-2023-momentum | 13/02/2024 |
| https://longevity.technology/news/bioage-announces-170-million-raise-to-accelerate-development-of-obesity-therapeutics/ | |
| https://www.businesswire.com/news/home/20240213546755/en/BioAge-Announces-170-Million-Oversubscribed-Series-D-Financing-to-Accelerate-Development-of-Obesity-and-Metabolic-Disease-Therapeutics | |
| Sudo's $147 Million Series B | https://www.sudobio.com/press-releases/021324/ | 13/02/2024 |
| ProfoundBio's $112 Million Series B...More More | https://www.fiercebiotech.com/biotech/profoundbio-3-adcs-already-clinic-rakes-112m-oversubscribed-series-b | 13/02/2024 |
| https://endpts.com/profoundbio-founded-by-former-seagen-leaders-nabs-112m-for-four-clinical-stage-adcs/ | |
| https://www.prnewswire.com/news-releases/profoundbio-raises-112-million-in-oversubscribed-series-b-equity-financing-to-advance-its-clinical-stage-antibody-drug-conjugate-adc-pipeline-302060191.html | |
| Areteia's $75 Million Series A Extension | https://www.businesswire.com/news/home/20240213672000/en/Areteia-Therapeutics-Announces-Additional-75MM-in-Series-A-Financing-for-Oral-Dexpramipexole-in-Eosinophilic-Asthma | 13/02/2024 |
| Codexis's $40 Million Debt Financing | https://www.globenewswire.com/news-release/2024/02/13/2828651/0/en/Codexis-Secures-40-Million-in-Strategic-Financing-Deal-with-Innovatus-Capital-Partners-to-Further-Strengthen-Cash-Position-Ahead-of-Key-Milestones.html | 13/02/2024 |
| CEL-SCI’s $8 Million Public Offering...More | https://www.businesswire.com/news/home/20240213353838/en/CEL-SCI-Announces-Closing-of-7.75-Million-Public-Offering-of-Common-Stock | 13/02/2024 |
| https://www.businesswire.com/news/home/20240209945546/en/CEL-SCI-Announces-Pricing-of-7.75-Million-Public-Offering-of-Common-Stock | |
| Telomir's $7 Million IPO...More | https://www.globenewswire.com/news-release/2024/02/13/2828642/0/en/Telomir-Pharmaceuticals-Announces-Closing-of-Initial-Public-Offering.html | 13/02/2024 |
| https://www.globenewswire.com/news-release/2024/02/08/2826500/0/en/Telomir-Pharmaceuticals-Announces-Pricing-of-Initial-Public-Offering.html | |
| Shuttle's $4 Million Rights Offering | https://www.prnewswire.com/news-releases/shuttle-pharma-announces-its-intent-to-pursue-a-rights-offering-302060196.html | 13/02/2024 |
| Kinea's $0.5 Million Grant from Venture Philanthropy | https://www.prnewswire.com/news-releases/parent-project-muscular-dystrophy-provides-500-000-in-funding-to-kinea-bio-through-ppmd-venture-pathways-program-to-support-next-gen-midi-dystrophin-gene-therapy-development-302060829.html | 13/02/2024 |
| BMS's $13 Billion Debt Financing | https://www.businesswire.com/news/home/20240214420778/en/Bristol-Myers-Squibb-Prices-13-Billion-of-Senior-Unsecured-Notes | 14/02/2024 |
| Cogent's $225 Million Private Placement | https://www.globenewswire.com/news-release/2024/02/14/2828971/0/en/Cogent-Biosciences-Announces-Oversubscribed-225-Million-Private-Placement.html | 14/02/2024 |
| enGene's $200 Million Private Placement | https://www.prnewswire.com/news-releases/engene-announces-oversubscribed-200-million-private-placement-financing-302061427.html | 14/02/2024 |
| Earlybird's $186 Million Fund Raise | https://www.fiercebiotech.com/biotech/earlybird-gets-eu173m-worm-european-vc-closes-healthcare-fund | 14/02/2024 |
| Helix's $184 Million IPO | https://finance.yahoo.com/news/helix-acquisition-corp-ii-announces-123000702.html | 14/02/2024 |
| NextPoint’s $42 Million Series B Extension…More | https://finance.yahoo.com/news/nextpoint-therapeutics-announces-closing-series-120000484.html | 14/02/2024 |
| https://www.businesswire.com/news/home/20240214915953/en/NextPoint-Therapeutics-Announces-Closing-of-Series-B-Financing-Extension-Led-by-Catalio-Capital-Management | |
| Latigo's $135 Million Venture Financing | https://www.fiercebiotech.com/biotech/latigo-raises-135m-it-runs-behind-vertex-non-opioid-pain-race | 14/02/2024 |
